1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East and Africa Allergy Treatment Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East and Africa Allergy Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East and Africa Allergy Treatment Market Regional Analysis
6.2 Middle East and Africa Allergy Treatment Market Revenue 2018-2028 (US$ Million)
6.3 Middle East and Africa Allergy Treatment Market Forecast Analysis
7. Middle East and Africa Allergy Treatment Market Analysis – by Allergy Type
7.1 Eye Allergy
- 7.1.1 Overview
- 7.1.2 Eye Allergy: Middle East and Africa Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)
7.2 Rhinitis
- 7.2.1 Overview
- 7.2.2 Rhinitis: Middle East and Africa Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)
7.3 Asthma
- 7.3.1 Overview
- 7.3.2 Asthma: Middle East and Africa Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)
7.4 Skin Allergy
- 7.4.1 Overview
- 7.4.2 Skin Allergy: Middle East and Africa Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)
7.5 Food Allergies
- 7.5.1 Overview
- 7.5.2 Food Allergies: Middle East and Africa Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)
7.6 Other Allergies
- 7.6.1 Overview
- 7.6.2 Other Allergies: Middle East and Africa Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)
8. Middle East and Africa Allergy Treatment Market Analysis – by Treatment
8.1 Anti-Allergy Drugs
- 8.1.1 Overview
- 8.1.2 Anti-Allergy Drugs: Middle East and Africa Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)
8.2 Immunotherapy
- 8.2.1 Overview
- 8.2.2 Immunotherapy : Middle East and Africa Allergy Treatment Market – Revenue and Forecast, 2018-2028 (US$ Million)
9. Middle East and Africa Allergy Treatment Market – Middle East and Africa Analysis
9.1 Overview
9.2 Middle East and Africa
- 9.2.1 Middle East and Africa Allergy Treatment Market Breakdown, by Key
Country, 2021 and 2028 (%)
- 9.2.1.1 Middle East and Africa Allergy Treatment Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 South Africa:
Middle East and Africa Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.1.1 South Africa: Middle East and Africa Allergy Treatment Market Breakdown, by Allergy Type
- 9.2.1.1.2 South Africa: Middle East and Africa Allergy Treatment Market Breakdown, by Treatment
- 9.2.1.2 Saudi Arabia:
Middle East and Africa Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.2.1 Saudi Arabia: Middle East and Africa Allergy Treatment Market Breakdown, by Allergy Type
- 9.2.1.2.2 Saudi Arabia: Middle East and Africa Allergy Treatment Market Breakdown, by Treatment
- 9.2.1.3 UAE:
Middle East and Africa Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.3.1 UAE: Middle East and Africa Allergy Treatment Market Breakdown, by Allergy Type
- 9.2.1.3.2 UAE: Middle East and Africa Allergy Treatment Market Breakdown, by Treatment
- 9.2.1.4 Rest of Middle East and Africa:
Middle East and Africa Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 9.2.1.4.1 Rest of Middle East and Africa: Middle East and Africa Allergy Treatment Market Breakdown, by Allergy Type
- 9.2.1.4.2 Rest of Middle East and Africa: Middle East and Africa Allergy Treatment Market Breakdown, by Treatment
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Johnson and Johnson Services, Inc.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Sanofi
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 AbbVie's Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Pfizer Inc.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 ALK-Abelló A/S
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Allergy Therapeutics
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Stallergenes Greer
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 GlaxoSmithKline PLC
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations